ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 945,26
-1,40%
Dow Jones
38 554,39
-0,77%
DAX
18 483,71
-1,08%
Brent Oil
83,885
-0,52%
Bitcoin
67 783,09
-0,74%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adaptive Biotechnologies Corporation (ADPT)

  7. Adaptive Biotechnologies Corporation (ADPT) Actualités

ADPT

Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADPT
DateHeureSourceTitreSymboleSociété
24/05/202418h01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ADPTAdaptive Biotechnologies Corporation
18/05/202400h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422h05GlobeNewswire Inc.Adaptive Biotechnologies Reports First Quarter 2024 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
17/04/202422h05GlobeNewswire Inc.Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
02/04/202422h05GlobeNewswire Inc.Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueNASDAQ:ADPTAdaptive Biotechnologies Corporation
27/03/202413h30GlobeNewswire Inc.Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
07/03/202401h38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
22/02/202422h05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
14/02/202422h05GlobeNewswire Inc.Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
29/01/202422h05GlobeNewswire Inc.Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
29/01/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADPTAdaptive Biotechnologies Corporation
27/12/202322h05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
09/12/202314h30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
05/12/202313h30GlobeNewswire Inc.Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
09/11/202322h05GlobeNewswire Inc.Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/11/202313h30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy PipelineNASDAQ:ADPTAdaptive Biotechnologies Corporation
02/11/202321h05GlobeNewswire Inc.Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023NASDAQ:ADPTAdaptive Biotechnologies Corporation
13/09/202313h30GlobeNewswire Inc.Adaptive Announces Launch of Epic Integration for clonoSEQ®NASDAQ:ADPTAdaptive Biotechnologies Corporation
30/08/202322h30GlobeNewswire Inc.Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
08/08/202323h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
02/08/202322h05GlobeNewswire Inc.Adaptive Biotechnologies Reports Second Quarter 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
10/07/202322h05GlobeNewswire Inc.Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023NASDAQ:ADPTAdaptive Biotechnologies Corporation
21/06/202312h02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ADPTAdaptive Biotechnologies Corporation
20/06/202323h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADPTAdaptive Biotechnologies Corporation
13/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADPTAdaptive Biotechnologies Corporation
02/06/202313h34GlobeNewswire Inc.Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic CancerNASDAQ:ADPTAdaptive Biotechnologies Corporation
24/05/202322h05GlobeNewswire Inc.Adaptive Biotechnologies to Participate in Upcoming June Investor ConferencesNASDAQ:ADPTAdaptive Biotechnologies Corporation
12/05/202314h00GlobeNewswire Inc.Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
 Showing the most relevant articles for your search:NASDAQ:ADPT

Dernières Valeurs Consultées

BIT
S29058
Societe Generale Effekten
LSE
60ED
Investec Bnk 24
COIN
FLITHUSD
Future Lithium
NASDAQ
BSJT
Invesco BulletShares 202...
COIN
HOMEEEUST
OtterHome
EU
CLE15
CAC 40 X15 Leverage NR
BOV
ABEVF202
ABEVF202 Ex:20,2
LSE
0MM4
LSE
43UL
Int.fin. 46
COIN
MBTCOETH
Minibitcoin
LSE
COMF
L&g All Com �
TG
SWF
Stanley Black and Decker
LSE
40YK
Int.fin. 46
NYSE
RJR
RJ Reynolds Tob
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés